Mumbai, February 5, 2025 –
Hikal Ltd. (BSE: 524735, NSE: HIKAL) announced its unaudited financial results for the quarter and nine months ended December 31, 2024. The company posted stable revenue figures amid ongoing regulatory proceedings.
Key Financial Highlights (Standalone)
| (INR Million) | Q3 FY25 | Q2 FY25 | Q3 FY24 | 9M FY25 | 9M FY24 | FY24 (Audited) |
|---|
| Revenue from Operations | 4,477 | 4,529 | 4,475 | 13,074 | 12,705 | 17,846 |
| Total Income | 4,513 | 4,533 | 4,476 | 13,119 | 12,725 | 17,871 |
| Total Expenses | 4,275 | 4,285 | 4,259 | 12,423 | 12,243 | 17,176 |
| Profit Before Tax | 239 | 246 | 217 | 555 | 482 | 954 |
| Profit for the Period | 173 | 179 | 163 | 416 | 336 | 665 |
| EPS (INR) – Basic & Diluted | 1.40 | 1.47 | 1.32 | 3.29 | 2.89 | 5.64 |
Segment Performance
- Pharmaceuticals: Revenue stood at INR 2,934 million in Q3 FY25, reflecting steady demand.
- Crop Protection: Revenue declined to INR 1,543 million compared to INR 1,589 million in Q2 FY25.
Dividend Declaration
The Board of Directors has declared an
interim dividend of INR 0.60 per share (30%) for FY2025.
Regulatory & Compliance Matters
The company remains engaged in legal proceedings related to
environmental compliance issues from January 2022. The Gujarat Pollution Control Board directed the company to pay
INR 174.5 million in compensation, which has been stayed by the
Supreme Court pending further hearings. The company has provisioned
INR 9.8 million for legal representation.
Management Commentary
Executive Chairman
Jai Hiremath stated,
"Despite ongoing regulatory challenges, our core operations continue to perform well, reflecting strong market positioning. We remain committed to legal compliance while driving sustainable growth."Outlook
Hikal Ltd. continues to focus on
enhancing operational efficiencies, product innovation, and regulatory compliance while navigating market challenges. Investors can anticipate
stable earnings momentum with ongoing legal prudence.
